Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 125312995 | 12531299 | 5 | F | 20160908 | 20160706 | 20160915 | PER | PHEH2016US016573 | NOVARTIS | 0.00 | F | Y | 0.00000 | 20160915 | CN | COUNTRY NOT SPECIFIED | US |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 125312995 | 12531299 | 1 | PS | GILENYA | FINGOLIMOD HYDROCHLORIDE | 1 | Oral | 0.5 MG, QD | 22527 | .5 | MG | CAPSULE | QD | ||||||
| 125312995 | 12531299 | 2 | SS | TERAZOSIN HCL | TERAZOSIN HYDROCHLORIDE | 1 | Unknown | 1 DF, PRN | U | 0 | 1 | DF | CAPSULE | ||||||
| 125312995 | 12531299 | 3 | SS | TERAZOSIN HCL | TERAZOSIN HYDROCHLORIDE | 1 | Unknown | 1 DF, PRN | U | 0 | 1 | DF | CAPSULE | ||||||
| 125312995 | 12531299 | 4 | C | LEVOXYL | LEVOTHYROXINE SODIUM | 1 | Unknown | U | 0 |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 125312995 | 12531299 | 1 | Multiple sclerosis |
| 125312995 | 12531299 | 2 | Nephrolithiasis |
| 125312995 | 12531299 | 4 | Product used for unknown indication |
Outcome of event
| no results found |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 125312995 | 12531299 | Asthenia | |
| 125312995 | 12531299 | Concomitant disease aggravated | |
| 125312995 | 12531299 | Confusional state | |
| 125312995 | 12531299 | Depression | |
| 125312995 | 12531299 | Disturbance in attention | |
| 125312995 | 12531299 | Energy increased | |
| 125312995 | 12531299 | Epigastric discomfort | |
| 125312995 | 12531299 | Feeling abnormal | |
| 125312995 | 12531299 | Sneezing | |
| 125312995 | 12531299 | Visual impairment |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 125312995 | 12531299 | 1 | 20160620 | 0 | ||
| 125312995 | 12531299 | 2 | 20160626 | 0 | ||
| 125312995 | 12531299 | 3 | 20160628 | 0 |